isoproterenol and periplocymarin

isoproterenol has been researched along with periplocymarin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Qian, L; Xu, H; Yuan, R; Yun, W	1

Other Studies

1 other study(ies) available for isoproterenol and periplocymarin

Article	Year
Periplocymarin protects against myocardial fibrosis induced by β-adrenergic activation in mice. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2021, Volume: 139 Topics: Adrenergic beta-Agonists; Animals; Cardiac Glycosides; Cardiomyopathies; Cyclooxygenase 2; Echocardiography; Extracellular Matrix; Fibrosis; Isoproterenol; Metabolic Networks and Pathways; Metabolomics; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Nitric Oxide Synthase Type III; Up-Regulation	2021

Article

Year

Periplocymarin protects against myocardial fibrosis induced by β-adrenergic activation in mice.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2021, Volume: 139

Topics: Adrenergic beta-Agonists; Animals; Cardiac Glycosides; Cardiomyopathies; Cyclooxygenase 2; Echocardiography; Extracellular Matrix; Fibrosis; Isoproterenol; Metabolic Networks and Pathways; Metabolomics; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Nitric Oxide Synthase Type III; Up-Regulation

2021